CINECA IRIS Institutional Research Information System

BOLDRINI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.398
AS - Asia 4.091
EU - Europa 2.675
SA - Sud America 658
Continente sconosciuto - Info sul continente non disponibili 200
AF - Africa 195
OC - Oceania 9
Totale 17.226
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.163
SG - Singapore 1.340
CN - Cina 1.190
IT - Italia 752
HK - Hong Kong 575
BR - Brasile 571
SE - Svezia 457
DE - Germania 335
VN - Vietnam 322
BG - Bulgaria 253
GB - Regno Unito 178
CA - Canada 174
TR - Turchia 174
FR - Francia 152
FI - Finlandia 140
RU - Federazione Russa 115
KR - Corea 101
UA - Ucraina 86
IN - India 80
CI - Costa d'Avorio 68
AT - Austria 53
BD - Bangladesh 53
JP - Giappone 48
IQ - Iraq 42
SN - Senegal 38
CH - Svizzera 30
AR - Argentina 29
MX - Messico 26
BE - Belgio 22
NL - Olanda 22
ZA - Sudafrica 22
ID - Indonesia 19
PL - Polonia 19
UZ - Uzbekistan 19
PK - Pakistan 17
ES - Italia 16
VE - Venezuela 15
NG - Nigeria 14
PH - Filippine 14
SA - Arabia Saudita 13
IE - Irlanda 12
JO - Giordania 12
MA - Marocco 12
CO - Colombia 11
AU - Australia 9
CL - Cile 8
EG - Egitto 8
JM - Giamaica 7
KE - Kenya 7
NP - Nepal 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
CR - Costa Rica 6
EC - Ecuador 6
IL - Israele 6
KZ - Kazakistan 6
LT - Lituania 6
TN - Tunisia 6
UY - Uruguay 6
AL - Albania 5
LB - Libano 5
OM - Oman 5
PY - Paraguay 5
BB - Barbados 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
MY - Malesia 4
PS - Palestinian Territory 4
TW - Taiwan 4
DO - Repubblica Dominicana 3
ET - Etiopia 3
GY - Guiana 3
HU - Ungheria 3
LU - Lussemburgo 3
NI - Nicaragua 3
RO - Romania 3
ZW - Zimbabwe 3
BH - Bahrain 2
BJ - Benin 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CG - Congo 2
GE - Georgia 2
IR - Iran 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
PA - Panama 2
PE - Perù 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
EU - Europa 1
Totale 17.010
Salva come PNG Salva come JPEG
Città #
Ashburn 1.009
Fairfield 736
Singapore 736
Woodbridge 587
Chandler 574
Hong Kong 566
Dallas 538
Santa Clara 513
San Jose 473
Ann Arbor 466
Houston 437
Seattle 299
Beijing 260
Sofia 253
Cambridge 248
Wilmington 248
Shanghai 233
New York 199
Council Bluffs 194
Boardman 127
Ottawa 126
Milan 121
Princeton 111
Hefei 109
Izmir 106
Pisa 106
Jacksonville 105
Lawrence 101
Los Angeles 101
Medford 95
Lauterbourg 93
Seoul 93
Nanjing 91
Serra 89
Des Moines 72
Florence 69
Abidjan 68
São Paulo 64
Ho Chi Minh City 62
Hanoi 53
Columbus 52
Istanbul 47
Buffalo 45
Frankfurt am Main 45
Munich 43
The Dalles 42
Tokyo 42
Vienna 39
Dakar 38
Dong Ket 36
San Diego 36
Boulder 35
Dearborn 33
Redondo Beach 33
Nanchang 32
Helsinki 29
Ogden 29
Bremen 28
Kunming 27
Chicago 26
Rome 26
Bern 24
London 24
Phoenix 24
Baghdad 23
Falls Church 22
Shenyang 22
Lancaster 21
Turku 20
Brussels 19
Hebei 19
Atlanta 18
Guangzhou 18
Rio de Janeiro 18
Tashkent 18
Jüchen 17
Fuzhou 16
Redwood City 16
Orem 15
Warsaw 15
Washington 15
Changsha 14
Montreal 14
Pune 14
Toronto 14
Baltimore 13
Cascina 13
Düsseldorf 13
Johannesburg 13
Belo Horizonte 12
Dhaka 12
Hangzhou 12
Amman 11
Lagos 11
Nuremberg 11
Nürnberg 11
San Francisco 11
Da Nang 10
Denver 10
Porto Alegre 10
Totale 11.907
Salva come PNG Salva come JPEG
Nome #
p16 and its putative interplay with metabolic factors in prostate cancer: An analysis based on public TCGA data 324
Steroid Hormones as Modulators of Emotional Regulation in Male Urogenital Cancers 285
Steroid Hormones Modulation of the Tumor Microenvironment in Prostate Cancer. 256
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines 250
Proposal for a New Diagnostic Histopathological Approach in the Evaluation of Ki-67 in GEP-NETs 228
Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance 228
EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center 219
Evaluation of telomerase in the development and progression of colon cancer. Int J Mol Med. 2002 Nov;10(5):589-92 217
C-MYC, HIF-1α, ERG, TKT, and GSTP1: an Axis in Prostate Cancer? 217
Distinct Angiogenic microRNA-mRNA Expression Profiles Among Subtypes of Lung Adenocarcinoma. 215
Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features 210
EZH2 Expression in Intestinal Neuroendocrine Tumors 210
Lung recurrence of papillary thyroid cancer diagnosed with antithyroglobulin antibodies after 10 years from initial treatment. 206
Analysis of Fusion Genes by NanoString System: A Role in Lung Cytology? 196
Differential microRNA expression profiles between young and old lung adenocarcinoma patients. 196
A high vascular count and overexpression of Vascular Endothelial Growth Factor (VEGF) are associated with unfavorable prognosis in operated Small Cell Carcinoma (SCLC) 193
Mutations of Fas (APO-1/CD95) and p53 genes in nonmelanoma skin cancer 193
Targeting of O6-methylguanine-DNA methyltransferase (MGMT) activity by antimessenger oligonucleotide sensitizes CHO/mex+ transfected cells to Mitozolomide 191
Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study 187
Alterations of Fas (APO-1/CD95) gene and its relationship with p53 in non small cell lung cancer 184
CD34 microvessel density and VEGF expression in basal and squamous cell carcinoma 184
Expression Profiling of LKB1 Pathway in Young and Old Lung Adenocarcinoma Patients. 182
Management of peritoneal carcinomatosis with cytoreductive surgery combined with intraperitoneal chemohyperthermia at a novel italian center 181
Neoangiogenesis and p53 protein in lung cancer: Their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression 180
3T3 NIH murine fibroblasts and B78 murine melanoma cells expressing the "E. coli" N3-methyladenine-DNA glycosylase I do not become resistant to alkylating agents" 178
Evaluation of telomerase in non-melanoma skin cancer 177
Effect of type I interferon(s) on cell viability and apoptosis in primary human thyrocyte cultures. 177
Neoangiogenesis as prognostic indicator of survival in lung cancer. 175
P2X7 protein expression and polymorphism in non-small cell lung cancer (NSCLC). 175
Anaplastic lymphoma kinase gene rearrangements in cytological samples of non-small cell lung cancer: comparison with histological assessment. 173
A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma 172
Inherited germline T790M mutation and somatic epidermal growth factor receptor mutations in non-small cell lung cancer patients 169
Expression profiling and microRNA regulation of the LKB1 pathway in young and aged lung adenocarcinoma patients 169
Immunohistochemical and molecular study of radiation-induced multiple meningiomas with pleural and pulmonary metastasis 168
VALUTAZIONE DELL'ATTIVITA' TELOMERASICA E DELL'ESPRESSIONE DI hTERT mRNA IN ADENOCARCINOMA DEL COLON 167
Identification of Fas (APO-1/CD95) and p53 gene mutations in non-small cell lung cancer 167
Primary small cell carcinoma of the ureter: Case report and review of the literature 167
Intraoperative sentinel lymph node mapping in stage I non-small cell lung cancer: detection of micrometastases by polymerase chain reaction 166
Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations 165
Intraductal prostate cancer: An aggressive subset of prostate cancers? Immunophenotypic evaluation 164
Effect of Interferon-α and β on FAS mediated apoptosis and IL-6 release in Human primary thyrocytes 161
COINVOLGIMENTO DEL SISTEMA FAS(CD95/APO-1)/FAS LIGANDO NEL PROCESSO DI APOPTOSI p53-MEDIATO IN ADENOCARCINOMI DEL COLON 160
Quantitation of in vitro activity of synthetic trans-acting ribozyme using HPLC 158
Multi-dimensional scaling analysis of key regulatory genes in prostate cancer using the tcga database 158
The genotoxicity of the chlroethylating agent Mitozolomide is enhanced in CHO MEX+ cells by the administration of antimessenger oligonucleotide targeted against Methylguanine-DNA methyltransferase gene (MGMT) 154
Expression and function of P2X7 receptor in papillary thyroid cancer: a new potential marker of the disease? 153
Gastrin-Releasing Peptide Receptor in Low Grade Prostate Cancer: Can It Be a Better Predictor Than Prostate-Specific Membrane Antigen? 152
Are Renal Cell Carcinoma with Fibromyomatous Stroma (RCC-FMS) and Thyroid-like Follicular Carcinoma of the Kidney (TLFCK) Really Independent Variants? 150
Delta N133p53 Expression Levels in Relation to Haplotypes of the TP53 Internal Promoter Region 150
Role of microRNA-33a in regulating the expression of PD-1 in lung adenocarcinoma. 150
Alterazioni del gene Fas (APO-1/CD95) nei carcinomi polmonari non a piccole cellule (NSCLC). Correlazioni con le alterazioni del gene P53. 149
The role of somatostatin in vasogenic meningioma associated brain edema 149
WSB1 Involvement in Prostate Cancer Progression 148
Regulation of telomerase and its hTERT messenger in colorectal cancer 148
Evaluation of telomerase mRNA (hTERT) in colon cancer 147
Differential microRNA Expression Profile between Young and Old Lung Adenocarcinoma Patients. 146
Unusual Case of Pancreatic Adenocarcinoma with Bladder Metastasis 145
Intraoperative sentinel lymph node mapping in stage I non-small cell lung cancer: detection of micrometastases by polymerase chain reaction 142
Alterations of Fas (APO-1/CD95) gene and its relationship with p53 in non small cell lung cancer 140
Meningioma-associated brain oedema: the role of angiogenic factors and pial blood supply 138
null 138
Osteopontin expression and prognostic significance in non-small cell lung cancer 137
Telomerase in intracranial meningiomas 137
The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib 137
Vascular endothelial growth factor is associated with neovascularization and influences progression in Non Small Cell Lung Carcinoma (NSCLC). Clin Cancer Research 3: 861-865, 1997 136
Expression of p-AKT and p-mTOR in a large series of bronchopulmonary neuroendocrine tumors 134
Tumor necrosis factor/a and trasforming growth/b are significantly associated with better prognosisi in non small cell lung carcinoma: putative relation with bcl-32-mediated neovascularization 131
Quantitation by competitive PCR assay of vascular endothelial growth factor (VEGF) in non-small cell lung carcinomas 130
Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance 130
null 130
Neoangiogenesis in colon cancer: Correlation between vascular density, vascular endothelial growth factor (VEGF) and p53 protein expression 130
Thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer and normal mucosa in patients 129
Expression of miRNA-25 in young and old lung adenocarcinoma 129
Prognostic role of TPL2 in early‑stage non‑small cell lung cancer 128
Modulation of neoangiogenesis in bronchial preneoplastic lesions 122
TSP1 and TSP2 mRNA expression in lung carcinoma: relation with p53 alterations, angiogenic growth factors and vascular density 120
Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas 120
NEOANGIOGENESI IN ADENOCARCINOMI DEL COLON 119
Bel2 and p53 regulate vascular endothelial growth factor(VEGF)-mediated angiogenesis in non-small cell lung carcinoma. 118
Vascular endothelial growth factor is associated with neovascularization and influences progression in Non Small Cell lung Carcinoma (NSCLC) 116
null 116
Mutational analysis in cytological specimens of advanced lung adenocarcinoma: A sensitive method for molecular diagnosis 115
Interferon Beta induces IL-6 release but not apoptosis in primary cultures of human thyrocytes 112
null 111
Telomerase activity and hTERT mRNA expression in gliomas 110
Non-small-cell lung cancer in women: Clinical and molecular aspects 107
Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization 107
Response to erlotinib in a patient with lung adenocarcinoma harbouring the EML4-ALK translocation: A case report. 105
Role of endothelin-1 in angiogenic phenomenon in intracranial meningiomas 104
Polymorphisms within inflammatory genes and colorectal cancer 104
Epidermal growth factor receptor and K-RAS mutations in 411 lung adenocarcinoma: A population-based prospective study 104
PLLA/Gelatine Spongy Matrices for the Regeneration of Bone Tissue 98
Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer 98
null 98
Regulation of telomerase and its hTERT messenger in colorectal cancer 97
Expression of cyclooxygenase-2 and its correlation with vasogenic brain edema in human intracranial meningiomas 95
Expression of endothelin-1 (ET-1) and cyclooxygenase-2 (COX-2) in intracranial meningiomas 93
Non-small-cell lung cancer in women: Clinical and molecular aspects 88
Expression of endothelia-1 is related to poor prognosis in non-small cell lung carcinoma Anno 2005 Titolo della Rivista Titolo EUROPEAN JOURNAL OF CANCER ISSN 0959-8049 88
P2X7 mRNA expression in non-small cell lung cancer: MicroRNA regulation and prognostic value 87
Totale 15.467
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.946
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.946
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.250 0 83 55 75 272 190 39 74 50 36 46 330
2022/20231.554 171 173 112 166 166 221 5 125 292 5 111 7
2023/2024925 86 78 126 34 137 194 32 44 17 14 60 103
2024/20253.650 29 127 24 213 394 443 325 190 346 458 380 721
2025/20263.990 296 505 567 229 429 328 639 166 204 361 87 179
2026/2027826 116 710 0 0 0 0 0 0 0 0 0 0
Totale 17.226